What is the HepTech Protocol?
The HepTech System is a group of three synergistic Medical Food products, including 38 therapeutically dosed liver supporting nutrients, whose efficacy in liver support is backed by over 300 PubMed papers. The HepTech System was formulated to support the dietary management of specific clinical manifestations of Hepatitis, including the progression of fibrosis to cirrhosis caused by Hepatitis.
Clinical manifestations of Hepatitis:
Hepatitis, whether the cause is a viral infection or otherwise, causes metabolic changes in patients and clinical manifestations of the disease, including:
- an increase in the generation of free radical reactive oxygen species (ROS) in the mitochondria of infected cells,
- an increase in cellular inflammation,
- steatosis: the abnormal accumulation of lipids inside the cells of the liver, cellular membrane and interior organelle membrane damage resulting in loss of membrane integrity, fluidity and function, and membrane phospholipid translocation,
- the activation of the cellular transcription factor NFkappaB.
- All of the above metabolic imbalances combine to cause a slow but persistent accumulation of scar tissue (fibrosis to cirrhosis) in the spaces of the liver.
Formulation of the HepTech Protocol:
The HepTech Comprehensive Medical Food Protocol is formulated to manage the distinctive nutritional requirements of Hepatitis patients and to ameliorate specific clinical manifestations of Hepatitis related impairment. These clinical manifestations include:
- increased levels of oxidative stress,
- increased levels of cellular inflammation,
- activation of NFkappaB,
- disruption of interior and exterior cellular membrane lipid profiles, fluidity, and function.
- These clinical manifestations all combine to trigger (through activation of NFkappaB) the generation of fibrosis to cirrhosis in the liver.
- The HepTech Protocol is designed to ameliorate these clinical manifestations of Hepatitis and thereby eliminate the triggers of fibrogenesis and stop the progression of fibrosis to cirrhosis in Hepatitis patients.